Brief: Anaptys To Receive $50 Mln In Capped Non-Recourse Monetization From Amended Agreement With Sagard In Exchange For Additional Jemperli Royalties
09/05/2024 21:29
May 9 (Reuters) - AnaptysBio Inc ANAB.O :
* ANAPTYS TO RECEIVE $50 MILLION IN A CAPPED NON-RECOURSE
MONETIZATION FROM AMENDED AGREEMENT WITH SAGARD IN EXCHANGE FOR
ADDITIONAL JEMPERLI ROYALTIES
Source text for Eikon: ID:nGNXgmfQL
Further company coverage: ANAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AnaptysBio
See all newsFirst Tracks Biotherapeutics up after $200 mln equity raise
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Brief: Anaptys Announces Second Quarter And Transitional Fiscal Year 2026 Financial Results And Provides Business Update
AnaptysBio Q2 collaboration revenue rises on higher Jemperli royalties